Cormorant Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.16M | Sell |
|
|||||
|
2019
Q4 | $4.22M | Hold |
|
|||||
|
2019
Q3 | $3.54M | Sell |
|
|||||
|
2019
Q2 | $4.22M | Sell |
|
|||||
|
2019
Q1 | $7.93M | Sell |
|
|||||
|
2018
Q4 | $15.6M | Buy |
|
|||||
|
2018
Q3 | $21.5M | Sell |
|
|||||
|
2018
Q2 | $18.8M | Hold |
|
|||||
|
2018
Q1 | $15.8M | Sell |
|
|||||
|
2017
Q4 | $15.5M | Sell |
|
|||||
|
2017
Q3 | $15.3M | Hold |
|
|||||
|
2017
Q2 | $11.5M | Sell |
|
|||||
|
2017
Q1 | $13M | Sell |
|
|||||
|
2016
Q4 | $13.9M | Sell |
|
|||||
|
2016
Q3 | $20.2M | Hold |
|
|||||
|
2016
Q2 | $18.1M | Sell |
|
|||||
|
2016
Q1 | $23.9M | Hold |
|
|||||
|
2015
Q4 | $34.2M | Sell |
|
|||||
|
2015
Q3 | $28.6M | Hold |
|
|||||
|
2015
Q2 | $34.3M | Hold |
|
|||||
|
2015
Q1 | $28.5M | Sell |
|
|||||
|
2014
Q4 | $22.3M | Buy |
|
|||||
|
2014
Q3 | $13.3M | Buy |
|
|||||
|
2014
Q2 | $4.45M | Buy |
|